Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results

FierceBiotechBeOne signs $2B deal for option on preclinical trispecific antibody from China’s Huahui

Cytiva (Google News)Rockwell Automation and Cytiva launch Figurate SCADA system to eliminate digital bottlenecks in biopharmaceutical manufacturing - Manufacturing Chemist

Endpoints NewsLack of specifics on obesity pill sales hover over Lilly’s first quarter

Endpoints NewsThe R&D 15: How pharma's top companies spent, won and lost on drug research

Endpoints NewsNovartis unveils North Carolina factory as final new build in $23B US expansion

FierceBiotechGSK’s $700M Alector bet blows up as Alzheimer’s drug flunks phase 2

10x Genomics News10x Genomics Inc (HAM:1KJ) Stock Earnings Transcripts - GuruFocus

FierceBiotechAvalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs

FierceBiotechAstraZeneca plucks preclinical EGFR degrader from Pinetree for $25M

Novo NordiskIs Novo Nordisk's GLP-1 dominance fading after Lilly's clinical wins? - MSN

Siemens HealthineersSiemens Healthineers: A €6 Billion Diagnostics Exit and a Coming Spin-Off as Shares Hit Rock Botto - AD HOC NEWS

BioPharma DiveAvalyn, in pursuit of better lung drugs, banks $300M in an IPO